Graduate School

GROW - School for Oncology and Reproduction

To all of our (scientific) staff and (external) PhD's: please note that our GROW Community is our main communication channel.

GROW focuses on research and teaching of genetic and cellular mechanisms, as well as environmental and life-style factors that underlie normal (embryonic and fetal) and abnormal (cancer) growth. The emphasis is on basic and translational research, aiming at innovative approaches for individualizing prevention, patient diagnosis, and treatment for genetically determined diseases and cancer.

GROW researcher Lizza Hendriks appointed member of The Young Academy

Lizza Hendriks

In 2021, Lizza Hendriks, Assistant Professor at research institute GROW, School for Oncology and Reproduction of Maastricht University will join The Young Academy. This is a platform of the Royal Netherlands Academy of Sciences, where young top scientists from different disciplines work together in the field of research and science policy.

About Lizza Hendriks

Dr Lizza Hendriks (1981) has worked at Maastricht UMC + as a lung specialist since 2012. Her focus area is thoracic oncology, in particular prevention and optimal treatment of brain metastases in lung cancer. In 2016, she earned her PhD on this topic. To gain in-depth knowledge of both research and medical oncology, she worked one year as a postdoc at the Gustave Roussy Institute in France.

Since 2019, Dr Hendriks has coordinated the clinical lung cancer research of the lung diseases department in Maastricht. She does this in addition to her clinical tasks and teaching. Currently, Dr Hendriks supervises six PhD students. Her research ambition is to develop personalised therapy (in terms of biomarkers and psychosocial and cognitive capacity) with a focus on prevention/optimal treatment of brain metastases, while preserving neurocognition. To achieve this, immunotherapy, targeted therapy and radiotherapy are applied, including the use of advanced imaging analysis techniques such as radiomics.

Dr Hendriks received several abstract awards as well as the Dirkje Postma Talent Award (incentive subsidy for her own research line) in 2019. She is (co-)author of more than 80 peer-reviewed articles.

The Young Academy

The Young Academy consists of talented researchers who share a broad interest in scientific practice, science policy and science communication. The Young Academy (De Jonge Akademie) is an independent body within the Royal Netherlands Academy of Sciences. Membership lasts for five years. Within De Jonge Akademie, Lizza Hendriks is particularly committed to early career policy, getting young people interested in and motivated for research. She will also contribute to the new Recognition and Rewards policy, with a focus on policy for physician researchers.

Research

GROW research activities in the areas of oncology and reproductive medicine are closely interrelated, revolving around the same basic concepts and research techniques. Scientists at GROW collaborate intensively with clinicians at the Maastricht Comprehensive Cancer Centre and the Centre for Genetics, Reproduction and Child Health.

 More on research 

Education

An important aim within GROW is training master's and PhD students in the fields of modern medicine and molecular life sciences.

 More on education 

We are GROW

News

  • Better chances for cancer in the liver

    Monday, August 15, 2022

    Our liver is a special organ: if you cut away part of it, in most cases a new piece of liver will grow back. If someone has cancer in the liver, the affected part of the liver can be surgically removed. But you can only do this if at least 30% of the liver remains. For many patients whose remaining liver is too small, this means that they cannot undergo surgery. But thanks to international research from Maastricht UMC+, the treatment options for cancer in the liver have now been significantly expanded.

    Read more
  • Large-scale research into personalised treatment for metastatic colorectal cancer

    Tuesday, March 29, 2022
    Read more
  • Universiteitssingel 40 Maastricht

    Status Comprehensive Cancer Centre for GROW and MUMC+

    Thursday, April 15, 2021

    The UM research institute GROW and the Maastricht UMC+ Oncology Centre and have together been accredited as a Comprehensive Cancer Centre by the Organisation of European Cancer Institutes (OECI).

    Read more
  • UM Researcher Lizza Hendriks appointed member of The Young Academy

    Tuesday, December 8, 2020 Read more
  • lambin

    “Creativity loves a crisis”

    Monday, November 2, 2020

    A radiation oncologist by training, Philippe Lambin does not limit his research to a single disease. His latest achievement: three European grants for his research on COVID-19.
     

    Read more
  • ERC logo

    ERC Starting Grant for Olga Zvonareva and Francesca Rapino

    Tuesday, September 8, 2020 Read more
  • ERC grant Marc Vooijs

    European grant for developing innovative cancer drug

    Monday, August 17, 2020 Read more
  • Philippe Lambin

    Obtaining research grants in times of corona

    Thursday, June 25, 2020

    A video interview with Prof. Philippe Lambin

    Read more
  • ERC logo

    ERC Proof of Concept Grant for the development and testing of AI software for lung cancer

    Monday, April 27, 2020

    In this ERC PoC project, we introduce fully automated software for fast, accurate, observer independent and reproducible detection and volumetric segmentation of (lung) tumours and metastases on CT images.

    Read more
  • Andre Dekker

    Improving healthcare with big data

    Monday, April 6, 2020

    Andre Dekker is a clinical physicist and professor of Clinical Data Science at Maastricht University, Maastricht UMC+ and the MAASTRO Clinic. Since 2010 he has led a research group. He has over 150 publications to his name and has supervised more than 25 PhD candidates.

    Read more

Calendar

No upcoming events

Follow us on social media

    • RT @LJSchouten: Alcohol kankerverwekkend? Veel mensen kennen de gevaren niet /via @NOS@GROW_UMhttps://t.co/d5esFwQfRv

      4 days 1 hour ago
    • A unique study on the loss of body weight and muscle mass (cachexia) occurring in pancreatic and ovarian cancer patients will be conducted by one of our research teams👇 https://t.co/24Pgv0XiqG

      4 days 18 hours ago
    • Can stem cells help repair damaged lungs? Read more about the project of our researcher Tim Wolfs!⬇️ https://t.co/2NXxdOa1Wo

      2 weeks 5 days ago
    • Find the video here: https://t.co/j6DRKjAR4m

      2 weeks 6 days ago
    • Our researcher Matty Weijenberg was invited to speak about the cancer atlas at L1!👇 https://t.co/7zefJLrrir

      2 weeks 6 days ago
    • RT @IKNL: 🚀De Nederlandse #Kankeratlas is gelanceerd. Deze geeft inzicht in de impact van kanker per regio voor 24 kankersoorten en voor al…

      3 weeks 23 hours ago
    • 👋𝗠𝗲𝗲𝘁 𝗼𝘂𝗿 𝗮𝗳𝗳𝗶𝗹𝗶𝗮𝘁𝗶𝗼𝗻 𝗽𝗿𝗼𝗳𝗲𝘀𝘀𝗼𝗿𝘀!
      Today we want you introduce you to #GROWmaastricht 𝗠𝗮𝗿𝘆𝘀𝗸𝗮 𝗝𝗮𝗻𝘀𝘀𝗲𝗻-𝗛𝗲𝗶𝗷𝗻𝗲𝗻, professor of Clinical Epidemiology at @VieCuri and GROW. Read our interview with her here.⤵️https://t.co/LNc48G8BWe

      1 month 3 weeks ago
    • Congratulations 𝗠𝗮𝘀𝗼𝘂𝗱 𝗭𝗮𝗺𝗮𝗻𝗶 𝗘𝘀𝘁𝗲𝗸𝗶 on receiving the 𝗞𝗡𝗔𝗪 𝗘𝗮𝗿𝗹𝘆 𝗖𝗮𝗿𝗲𝗲𝗿 𝗔𝘄𝗮𝗿𝗱!🏆 Read more about Masoud and his research below.👇

      @MasoudZamaniE | @_knaw | #GROWmaastricht

      https://t.co/SHjTncHfP0

      2 months 1 week ago
    • A new decision aid for patients with pancreatic cancer developed by our researchers launches today!💡
      Read more here: https://t.co/K1TzkdRdtG

      2 months 3 weeks ago
    • The TEFAF fellowship has been awarded to our PhD candidate 𝗠𝗲𝗶𝗸𝗲 𝗧𝗵𝗶𝗷𝘀𝘀𝗲𝗻. As part of the fellowship Meike will work on her research project at the @BardelliLab in Milano in 2023!🌍
      Read more here: https://t.co/dKRNQEMmZn

      2 months 3 weeks ago
Maastricht University Medical Center (MUMC+) logo

GROW works in close cooperation with the Maastricht University Medical Center+ (MUMC+). MUMC+ is known both nationally and internationally for its focus on prevention and taking an integrated approach to health care: from prevention, promotion of good health, and basic care, to top-level clinical diagnostics and treatment. Patient safety is our top priority in all of our endeavours. MUMC+ is part of The Netherlands Federation of University Medical Centres.